NRXP 241220 7.50P (NRXP241220P7500) Stock Options, News & Quotes

0.00
0.000.00%

15min DelayClose Nov 25 09:30 ET

0.00High0.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Jaguar8

17 hours ago

NEWS

$NRX Pharmaceuticals (NRXP.US)$
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"
NRx Pharmaceuticals announced the publication of a paper in the American Journal of Clinical Psychopharmacology highlighting their improved methodology for depression rating quality assurance in clinical trials. The company developed an enhanced training and monitoring program for study site raters that achieved 94.5...

Teddy123

Nov 18 06:31

Chance going up?

$NRX Pharmaceuticals (NRXP.US)$

TheOracleOfBroMaha

Nov 14 11:40

So…. File to SELL 3,000,000 shares Rt NOW

$NRX Pharmaceuticals (NRXP.US)$ Right after DELAYED Earnings… Annnnd, i WONDER IF THEYRE DUMPING..!?? Shit like this- @ElonMusk Just put yourselves in jail. But thank you for the heads up at least I got a chance to sell my crap before you dump yours. I guess we’ll see right? I’m gonna keep this on my earnings calendar and can’t wait to see the stock go to $.03 next week.

Teddy123

Oct 31 07:53

NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule

$NRX Pharmaceuticals (NRXP.US)$

Trytosaveabit

Oct 30 06:51

News

$NRX Pharmaceuticals (NRXP.US)$ HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics
2 MINUTES AGO, 7:47 AM EDT
VIA PR NEWSWIRE
• The clinics are located in favorable locations, are revenue generating and EBITDA positive
• Clinics offer a comprehensive range of mental health services
• Acquisition is expected to be immediately accretive to revenue and EBITDA for HOPE and NRx